z-logo
open-access-imgOpen Access
IL‑6 inhibitors effectively reverse post‑infarction cardiac injury and ischemic myocardial remodeling via the TGF‑β1/Smad3 signaling pathway
Author(s) -
Jiahong Wang,
Minghong Wang,
Xiancheng Lu,
Yi Zhang,
Siliang Zeng,
Xin Pan,
Yimeng Zhou,
Hui Wang,
Nannan Chen,
Fengfeng Cai,
Ewelina Biskup
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11513
Subject(s) - medicine , fibrosis , myocardial infarction , myocardial fibrosis , ventricular remodeling , smad , cardiac fibrosis , signal transduction , cardiology , transforming growth factor , biology , microbiology and biotechnology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom